Keywords: ut, remodulin, up, fda, review, united, therapeutics

UT's Remodulin up for FDA review

Article | 04 July 2001

Print This

United Therapeutics has been requested to present data on itsprostacyclin analog Remodulin (UT-15) to the US Food and Drug Administration's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in